ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

Fermentalg lists on Euronext Paris

Share On Facebook
share on Linkedin
Print

EnterNext, the Euronext subsidiary designed to promote and grow its market for SMEs, has congratulated Fermentalg, an industrial biotechnology company producing oils and proteins from microalgae, on its listing on Euronext’s regulated market in Paris (compartment C).

Founded in 2009 par Pierre Calleja, Fermentalg is an industrial biotechnology company that specialises in producing sustainable oils and proteins derived from the exceptional properties of microalgae. Its patented technology allows it to target a range of fast-growing global markets, from nutrition and animal feed to cosmetics and health, green chemistry and energy. Fermentalg has already signed its first industrial and commercial joint venture for the production of Omega-3 oils rich in EPA and DHA, as well as several other partnerships with leading industrial groups.

Fermentalg (ticker symbol: FALG) was listed through the admission to trading of 7,399,000 existing shares making up the company’s equity and 4,486,091 new shares issued under a Global Offering, including full exercise of the extension option and the over-allotment option.

The company’s IPO was targeted at both French and international institutional investors, as well as individual investors. Total demand amounted to €135 million and the offer was oversubscribed 4.5 times.

The admission and issue price of Fermentalg shares was set at €9.00 per share, at the top end of the indicative price range. The company’s market capitalisation stood at around €107 million. A total of €40.4 million was raised.

“We want to extend a warm welcome to Fermentalg as it lists on Euronext Paris, in an IPO whose resounding success will help raise the company’s profile in France and abroad. And we are delighted at this opportunity to accompany Fermentalg as it moves ahead with new projects, which will benefit from the financing options offered by the Bourse” said Eric Forest, Chairman and CEO of EnterNext.

Pierre Calleja, founder and Chairman & CEO of Fermentalg added, “We are very pleased with the positive response to our company and the clear success of our IPO. And we would like to thank all of the new investors who have joined us, along with the existing shareholders who renewed their trust in us. Thanks to the funds raised, we now have the financial resources to go out and win markets as we scale up for full industrialization and commercialisation of our first products — creating a new champion to seize the ocean of opportunities that awaits.”

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Ltd. ADVFN Ltd does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

Leave A Reply

 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com